CN1948466B - 用于制备骨髓间充质干细胞的试剂盒 - Google Patents
用于制备骨髓间充质干细胞的试剂盒 Download PDFInfo
- Publication number
- CN1948466B CN1948466B CN200610114476A CN200610114476A CN1948466B CN 1948466 B CN1948466 B CN 1948466B CN 200610114476 A CN200610114476 A CN 200610114476A CN 200610114476 A CN200610114476 A CN 200610114476A CN 1948466 B CN1948466 B CN 1948466B
- Authority
- CN
- China
- Prior art keywords
- test kit
- percentage concentration
- culture fluid
- liquid
- volume percentage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000000130 stem cell Anatomy 0.000 title abstract description 4
- 210000001185 bone marrow Anatomy 0.000 title description 10
- 239000003153 chemical reaction reagent Substances 0.000 title description 8
- 210000004027 cell Anatomy 0.000 claims abstract description 76
- 239000000243 solution Substances 0.000 claims abstract description 75
- 239000007788 liquid Substances 0.000 claims abstract description 73
- 239000012930 cell culture fluid Substances 0.000 claims abstract description 64
- 238000010494 dissociation reaction Methods 0.000 claims abstract description 49
- 230000005593 dissociations Effects 0.000 claims abstract description 49
- 244000309466 calf Species 0.000 claims abstract description 17
- 210000002966 serum Anatomy 0.000 claims abstract description 17
- 239000002609 medium Substances 0.000 claims abstract description 14
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims abstract description 9
- 229920001612 Hydroxyethyl starch Polymers 0.000 claims abstract description 9
- 229940050526 hydroxyethylstarch Drugs 0.000 claims abstract description 9
- 238000012360 testing method Methods 0.000 claims description 70
- 210000004271 bone marrow stromal cell Anatomy 0.000 claims description 59
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 55
- 235000015097 nutrients Nutrition 0.000 claims description 29
- 238000005406 washing Methods 0.000 claims description 27
- 239000003085 diluting agent Substances 0.000 claims description 16
- 239000002504 physiological saline solution Substances 0.000 claims description 16
- 102000004142 Trypsin Human genes 0.000 claims description 11
- 108090000631 Trypsin Proteins 0.000 claims description 11
- 239000012588 trypsin Substances 0.000 claims description 11
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 7
- 102100025961 Glutaminase liver isoform, mitochondrial Human genes 0.000 claims description 7
- 101710138819 Glutaminase liver isoform, mitochondrial Proteins 0.000 claims description 7
- 229920003091 Methocel™ Polymers 0.000 claims description 5
- 235000011114 ammonium hydroxide Nutrition 0.000 claims 1
- 238000010790 dilution Methods 0.000 abstract description 10
- 239000012895 dilution Substances 0.000 abstract description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 abstract 1
- 235000014633 carbohydrates Nutrition 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 239000012894 fetal calf serum Substances 0.000 abstract 1
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 abstract 1
- 230000000050 nutritive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 30
- 238000002360 preparation method Methods 0.000 description 29
- 238000012856 packing Methods 0.000 description 18
- 230000000694 effects Effects 0.000 description 15
- 238000012258 culturing Methods 0.000 description 10
- 238000002156 mixing Methods 0.000 description 8
- 206010019280 Heart failures Diseases 0.000 description 6
- 206010000891 acute myocardial infarction Diseases 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 210000005087 mononuclear cell Anatomy 0.000 description 4
- 210000004165 myocardium Anatomy 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000002054 transplantation Methods 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 229920001917 Ficoll Polymers 0.000 description 2
- 238000002659 cell therapy Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000002831 pharmacologic agent Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000009168 stem cell therapy Methods 0.000 description 2
- 238000009580 stem-cell therapy Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 208000033774 Ventricular Remodeling Diseases 0.000 description 1
- 241000282485 Vulpes vulpes Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000001815 biotherapy Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008828 contractile function Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000001174 endocardium Anatomy 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 244000309715 mini pig Species 0.000 description 1
- 230000009756 muscle regeneration Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002363 skeletal muscle cell Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610114476A CN1948466B (zh) | 2006-11-10 | 2006-11-10 | 用于制备骨髓间充质干细胞的试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610114476A CN1948466B (zh) | 2006-11-10 | 2006-11-10 | 用于制备骨髓间充质干细胞的试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1948466A CN1948466A (zh) | 2007-04-18 |
CN1948466B true CN1948466B (zh) | 2010-05-12 |
Family
ID=38018091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200610114476A Expired - Fee Related CN1948466B (zh) | 2006-11-10 | 2006-11-10 | 用于制备骨髓间充质干细胞的试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1948466B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102492654A (zh) * | 2011-12-28 | 2012-06-13 | 葛龙海 | 一种分离人脐带血干细胞的试剂盒及其使用方法 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101412985B (zh) * | 2007-10-15 | 2012-06-13 | 华东理工大学 | 用于骨髓间充质干细胞体外培养和扩增的无血清培养基 |
CN102321582A (zh) * | 2011-08-29 | 2012-01-18 | 深圳市中美康士生物科技有限公司 | 一种粒细胞分离液及其粒细胞分离及活性测定方法 |
CN102643781B (zh) * | 2012-02-23 | 2014-09-10 | 中航(宁夏)生物有限责任公司 | 一种优化的有核细胞体外分离试剂盒及使用方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1330142A (zh) * | 2001-07-09 | 2002-01-09 | 中国人民解放军军事医学科学院野战输血研究所 | 人骨髓和脐带血间充质干细胞体外分离扩增和向神经细胞定向诱导的方法 |
WO2003101202A1 (en) * | 2002-05-31 | 2003-12-11 | Osiris Therapeutics, Inc. | Intraperitoneal delivery of genetically engineered mesenchymal stem cells |
CN1570088A (zh) * | 2004-05-10 | 2005-01-26 | 成都军区昆明总医院 | 神经细胞提取物及其在间充质干细胞诱导分化中的应用 |
CN1597937A (zh) * | 2004-07-20 | 2005-03-23 | 成都军区昆明总医院 | 胎盘羊膜细胞提取物及其在间充质干细胞诱导分化中的应用 |
-
2006
- 2006-11-10 CN CN200610114476A patent/CN1948466B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1330142A (zh) * | 2001-07-09 | 2002-01-09 | 中国人民解放军军事医学科学院野战输血研究所 | 人骨髓和脐带血间充质干细胞体外分离扩增和向神经细胞定向诱导的方法 |
WO2003101202A1 (en) * | 2002-05-31 | 2003-12-11 | Osiris Therapeutics, Inc. | Intraperitoneal delivery of genetically engineered mesenchymal stem cells |
CN1570088A (zh) * | 2004-05-10 | 2005-01-26 | 成都军区昆明总医院 | 神经细胞提取物及其在间充质干细胞诱导分化中的应用 |
CN1597937A (zh) * | 2004-07-20 | 2005-03-23 | 成都军区昆明总医院 | 胎盘羊膜细胞提取物及其在间充质干细胞诱导分化中的应用 |
Non-Patent Citations (2)
Title |
---|
梁峰等.体外诱导人骨髓间充质干细胞定向血管内皮细胞分化.中国医学科学院学报27 6.2005,27(6),665-669. |
梁峰等.体外诱导人骨髓间充质干细胞定向血管内皮细胞分化.中国医学科学院学报27 6.2005,27(6),665-669. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102492654A (zh) * | 2011-12-28 | 2012-06-13 | 葛龙海 | 一种分离人脐带血干细胞的试剂盒及其使用方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1948466A (zh) | 2007-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106434557B (zh) | 由脐带间充质干细胞制备cd34阳性细胞的方法 | |
JP6220791B2 (ja) | 増強された幹細胞組成物 | |
JP2019527040A5 (zh) | ||
CN101914495A (zh) | 用于体外大量扩增毛囊干细胞的培养方法 | |
CN101288779A (zh) | 基于温敏性壳聚糖水凝胶的可注射性心肌组织工程产品 | |
CN1948466B (zh) | 用于制备骨髓间充质干细胞的试剂盒 | |
CN109385396A (zh) | 临床应用级脐带间充质干细胞及其分离制备方法 | |
Eschenhagen et al. | How to repair a broken heart with pluripotent stem cell-derived cardiomyocytes | |
CN102807967A (zh) | 乳牙牙髓在制备间充质干细胞中的应用和乳牙牙髓间充质干细胞的培养方法 | |
CN105779381A (zh) | 临床治疗级细胞治疗用人脐带来源(WJ-MSCs)规模化细胞外基质筛选三维附着制备方法 | |
CN103320382A (zh) | 从胎盘和脐带中同时提取和纯化多种来源干细胞的方法 | |
CN108135942A (zh) | 基于脂肪来源的干细胞的干细胞疗法 | |
WO2007048352B1 (en) | Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries | |
CN105647860A (zh) | 临床治疗级人胎盘底蜕膜来源的间充质干细胞(PDB-MSCs)无血清体外提取制备方法 | |
CN105505863A (zh) | 一种裸鼹鼠心肌细胞的培养方法 | |
Ghodsizad et al. | Intraoperative isolation and processing of BM-derived stem cells | |
KR20080091874A (ko) | 인간 원종 줄기세포들을 자가 배양하기 위한 배지와 그의 응용 | |
CN106701682A (zh) | 由脐血分离造血干细胞并扩增cd34阳性细胞的方法 | |
Hayashi et al. | How do resident stem cells repair the damaged myocardium? | |
CN109820869A (zh) | 一种用于腔隙注射治疗骨关节炎的人源脐带间充质干细胞注射液的制备方法 | |
CN101161249A (zh) | 从剖腹产胎盘组织中提取原始间充质和造血干/祖细胞用于治疗骨髓损伤的方法 | |
CN111544453B (zh) | 一种包含三种血管再生属性的混合干细胞注射液及其制备方法 | |
CN109423477A (zh) | 用于制备脐带间充质干细胞的试剂盒 | |
CN1281740C (zh) | 一种细胞分化诱导剂、其制备方法及其在对干细胞向心肌组织细胞分化诱导中的应用 | |
RU2272638C1 (ru) | Биотрансплантат, способ его получения и способ лечения хронического гепатита и цирроза печени (варианты) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070418 Assignee: SOUTH CHINA CENTER FOR STEM CELL BIOLOGY AND REGENERATIVE MEDICINE OF ACADEMY OF MILITARY MEDICAL SCIENCES Assignor: INSTITUE OF TRANSFUSION MEDICINE, ACADEMY OF MILITARY MEDICAL SCIENCES, PEOPLE'S LIBRATION ARMY OF CHINA Contract record no.: 2015990000123 Denomination of invention: Reagent box used for preparing bone marrow interstitial stem cell Granted publication date: 20100512 License type: Exclusive License Record date: 20150324 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100512 |